Nintedanib

From WikiMD.org
Jump to navigation Jump to search

Nintedanib

Nintedanib (pronounced nin-ted-a-nib) is a medication used in the treatment of idiopathic pulmonary fibrosis and some types of cancer. It is a small molecule that inhibits multiple receptor tyrosine kinases.

Etymology

The name "Nintedanib" is derived from the chemical name of the drug, which is Nintedanib ethanesulfonate. The prefix "Nin-" is derived from the chemical structure of the drug, which contains a nintedanib moiety. The "-danib" suffix is common in drugs that inhibit tyrosine kinases.

Usage

Nintedanib is used in the treatment of idiopathic pulmonary fibrosis (IPF), a condition that causes progressive scarring of the lungs. It is also used in the treatment of some types of cancer, including non-small cell lung cancer and colorectal cancer.

Mechanism of Action

Nintedanib works by inhibiting multiple receptor tyrosine kinases, which are enzymes that play a key role in cell growth and proliferation. By inhibiting these enzymes, Nintedanib can slow the growth of cancer cells and reduce the progression of fibrosis in the lungs.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski